• image description

    UW Researchers Demonstrate Mild Brain Cooling After Head Injury Prevents Epileptic Seizures in Lab Study

    [Excerpted from UW Today] According to an animal study reported this month in the Annals of Neurology, mild cooling of the brain after a head injury prevents the later development of epileptic seizures. “These findings demonstrate for the first time that prevention of epileptic seizures after traumatic brain brain injury is possible, and that epilepsy prophylaxis in patients could be achieved more easily than previouslyView More

  • image description

    UW Spin-out PhysioSonics Gets FDA Approval for Monitoring Brain Blood Flow

    PhysioSonics, a UW spin-out company founded in 2000 by Robert Frederickson, Michel Kliot, Pierre Mourad, and Jeffrey Jarvik, has won approval from the FDA to start selling its Presto 1000 Flow Monitor system in the U.S., according to CEO Brad Harlow. The technology automates the way technicians and physicians monitor blood flow in the brain. Instead of having a technician manually hold an ultrasound transducerView More

  • image description

    UW Spin-out Cardiac Insight’s Heart Monitor and Software featured in Seattle Business Magazine

    In 2010, UW cardiologist David Linker founded the start-up Cardiac Insight with CEO Brad Harlow to produce a device, called the Stealth Ambulatory Monitor, which uses an algorithm that quickly and accurately detects an irregular heartbeat. It’s the size of a watchband and weighs a quarter of an ounce. Cardiac Insight is licensing the patent for the monitor from the University of Washington. “We’ve madeView More

  • image description

    C4C AnnouncesFall 2012 Commercialization Gap Fund Awards

    Nine Research Teams Receive $420,000 to Develop Fledgling Technologies The UW Center for Commercialization (C4C) today announced the award of $420,000 in Commercialization Gap Funds (CGF) to nine UW research teams currently working on promising technologies. The CGF program is a partnership between the C4C and the Washington Research Foundation to provide up to $1.25 million per year to support projects that have a highView More

  • image description

    UW’s Promising Therapeutic for Celiac Disease featured in “Chemical and Engineering News”

    Celiac disease is one of several diseases involving intolerance to dietary gluten protein that causes serious health problems. UW researcher Ingrid Swanson Pultz and Justin Siegel of the University of California at Davis are developing a promising therapeutic for celiac disease and gluten intolerance that was invented using advanced computational enzyme design. The result, KumaMax, breaks down gluten under the harsh conditions of the humanView More

  • image description

    UW Spin-out SNUPI launches with $1.5 million in funding

    SNUPI Technologies, a new UW spin-out company that takes advantage of the wiring already in homes to create a wireless sensor network, launched today with $1.5 million in funding from Madrona Venture Group, Radar Partners and the founders. The technology, also called SNUPI (Sensor Network Utilizing Powerline Infrastructure), was developed at the University of Washington and Georgia Institute of Technology by Professors Shwetak Patel andView More

  • image description

    UW Spinout Kona Medical Raises $10 Million More in Series C Funding

    Kona Medical Inc. has raised $10 million in new Series C equity and debt financing.That brings its Series C total to $40 million, including $30 million raised in May. The Series C round included two large-cap strategic investors who joined with prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western Technology Investments, BioStar Ventures, and individuals in the financing. Silicon Valley Bank provided the debtView More